0001104659-21-153333.txt : 20211223 0001104659-21-153333.hdr.sgml : 20211223 20211223214243 ACCESSION NUMBER: 0001104659-21-153333 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211222 FILED AS OF DATE: 20211223 DATE AS OF CHANGE: 20211223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paykel Neela CENTRAL INDEX KEY: 0001894593 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39949 FILM NUMBER: 211518755 MAIL ADDRESS: STREET 1: 530 OLD WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Hyperfine, Inc. CENTRAL INDEX KEY: 0001833769 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 NEW WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 BUSINESS PHONE: 866-796-6767 MAIL ADDRESS: STREET 1: 351 NEW WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 FORMER COMPANY: FORMER CONFORMED NAME: HealthCor Catalio Acquisition Corp. DATE OF NAME CHANGE: 20201124 4 1 tm2135698-16_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-22 0 0001833769 Hyperfine, Inc. HYPR 0001894593 Paykel Neela C/O HYPERFINE, INC. 530 OLD WHITFIELD STREET GUILFORD CT 06437 0 1 0 0 Gen Counsel & Corp Secretary Stock Option (right to buy) 3.27 2021-12-22 4 A 0 98250 A 2031-04-27 Class A Common Stock 98250 98250 D The shares underlying this option vested as to 25% on June 30, 2022, with the remainder of the options vesting in equal monthly installments over the following three years, subject to Ms. Paykel's continued service through the applicable vesting date. In connection with the closing of the transactions contemplated by the Business Combination Agreement, dated as of July 7, 2021, by and among HealthCor Catalio Acquisition Corp. ("HealthCor"), Optimus Merger Sub I, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub I"), Optimus Merger Sub II, Inc., a Delaware corporation and wholly owned subsidiary of HealthCor ("Merger Sub II"), Hyperfine, Inc., a Delaware corporation ("Hyperfine"), and Liminal Sciences, Inc., a Delaware corporation ("Liminal"), pursuant to which Merger Sub I merged with and into Hyperfine (the "Hyperfine Merger"), with Hyperfine surviving the Hyperfine Merger as a wholly owned subsidiary of HealthCor, and Merger Sub II merged with and into Liminal (the "Liminal Merger" and, together with the Hyperfine Merger, the "Mergers"), with Liminal surviving the Liminal Merger as a wholly owned subsidiary of HealthCor (which changed its name to "Hyperfine, Inc.", the "Issuer"), the option was received in the Mergers in exchange for a stock option to acquire 300,000 shares of Hyperfine common stock for $1.07. /s/ John P. Condon, Attorney-in-Fact 2021-12-23